JP2014070075A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014070075A5 JP2014070075A5 JP2013228826A JP2013228826A JP2014070075A5 JP 2014070075 A5 JP2014070075 A5 JP 2014070075A5 JP 2013228826 A JP2013228826 A JP 2013228826A JP 2013228826 A JP2013228826 A JP 2013228826A JP 2014070075 A5 JP2014070075 A5 JP 2014070075A5
- Authority
- JP
- Japan
- Prior art keywords
- dihydrobenzo
- triazol
- oxazepin
- imidazo
- isopropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 1- (2,4-Difluorophenyl) -1H-1,2,4-triazol-5-yl Chemical group 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000003226 pyrazolyl group Chemical group 0.000 claims 6
- 206010028980 Neoplasm Diseases 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- LWZYUACNWRVDDJ-UHFFFAOYSA-N 1-benzoxepine Chemical group O1C=CC=CC2=CC=CC=C12 LWZYUACNWRVDDJ-UHFFFAOYSA-N 0.000 claims 3
- FSGDNSSAEHNEAS-UHFFFAOYSA-N 2-[4-[2-(5-methyl-2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]ethanol Chemical compound CC(C)N1N=C(C)N=C1C1=CN(CCOC=2C3=CC=C(C=2)C2=CN(CCO)N=C2)C3=N1 FSGDNSSAEHNEAS-UHFFFAOYSA-N 0.000 claims 3
- QKZHALLNBLDACB-UHFFFAOYSA-N 2-methyl-1-[4-[2-(2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]propan-2-ol Chemical compound CC(C)N1N=CN=C1C1=CN(CCOC=2C3=CC=C(C=2)C2=CN(CC(C)(C)O)N=C2)C3=N1 QKZHALLNBLDACB-UHFFFAOYSA-N 0.000 claims 3
- BEUQXVWXFDOSAQ-UHFFFAOYSA-N 2-methyl-2-[4-[2-(5-methyl-2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]propanamide Chemical compound CC(C)N1N=C(C)N=C1C1=CN(CCOC=2C3=CC=C(C=2)C2=CN(N=C2)C(C)(C)C(N)=O)C3=N1 BEUQXVWXFDOSAQ-UHFFFAOYSA-N 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 125000002883 imidazolyl group Chemical group 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 125000001425 triazolyl group Chemical group 0.000 claims 3
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 208000032612 Glial tumor Diseases 0.000 claims 2
- 206010018338 Glioma Diseases 0.000 claims 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 2
- 206010033128 Ovarian cancer Diseases 0.000 claims 2
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 201000005202 lung cancer Diseases 0.000 claims 2
- 208000020816 lung neoplasm Diseases 0.000 claims 2
- 201000001441 melanoma Diseases 0.000 claims 2
- 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 claims 1
- 108091007960 PI3Ks Proteins 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 0 CC(C(*)CC=C1)N=C1NC Chemical compound CC(C(*)CC=C1)N=C1NC 0.000 description 7
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24638109P | 2009-09-28 | 2009-09-28 | |
| US61/246,381 | 2009-09-28 | ||
| US33068510P | 2010-05-03 | 2010-05-03 | |
| US61/330,685 | 2010-05-03 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012530282A Division JP5540101B2 (ja) | 2009-09-28 | 2010-09-27 | ベンゾオキサゼピンｐｉ３ｋ阻害剤化合物及び使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014070075A JP2014070075A (ja) | 2014-04-21 |
| JP2014070075A5 true JP2014070075A5 (enExample) | 2014-08-07 |
| JP5625101B2 JP5625101B2 (ja) | 2014-11-12 |
Family
ID=43037239
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012530282A Active JP5540101B2 (ja) | 2009-09-28 | 2010-09-27 | ベンゾオキサゼピンｐｉ３ｋ阻害剤化合物及び使用方法 |
| JP2013228826A Active JP5625101B2 (ja) | 2009-09-28 | 2013-11-01 | ベンゾオキサゼピンｐｉ３ｋ阻害剤化合物及び使用方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012530282A Active JP5540101B2 (ja) | 2009-09-28 | 2010-09-27 | ベンゾオキサゼピンｐｉ３ｋ阻害剤化合物及び使用方法 |
Country Status (31)
| Country | Link |
|---|---|
| US (7) | US8242104B2 (enExample) |
| EP (3) | EP2483278B1 (enExample) |
| JP (2) | JP5540101B2 (enExample) |
| KR (1) | KR101428346B1 (enExample) |
| CN (2) | CN104744491B (enExample) |
| AR (1) | AR078187A1 (enExample) |
| AU (1) | AU2010299816C1 (enExample) |
| BR (1) | BR112012006807A2 (enExample) |
| CA (1) | CA2772691C (enExample) |
| CL (1) | CL2012000754A1 (enExample) |
| CO (1) | CO6491026A2 (enExample) |
| CR (1) | CR20120121A (enExample) |
| DK (1) | DK2483278T3 (enExample) |
| EC (1) | ECSP12011755A (enExample) |
| ES (2) | ES2444779T3 (enExample) |
| HR (1) | HRP20140229T1 (enExample) |
| IL (2) | IL217558A (enExample) |
| MA (1) | MA33531B1 (enExample) |
| MX (1) | MX2012003591A (enExample) |
| MY (2) | MY184074A (enExample) |
| NZ (1) | NZ597833A (enExample) |
| PE (1) | PE20121025A1 (enExample) |
| PL (1) | PL2483278T3 (enExample) |
| PT (1) | PT2483278E (enExample) |
| RS (1) | RS53164B (enExample) |
| RU (2) | RU2654068C1 (enExample) |
| SG (1) | SG10201405049RA (enExample) |
| SI (1) | SI2483278T1 (enExample) |
| TW (1) | TWI423980B (enExample) |
| WO (1) | WO2011036280A1 (enExample) |
| ZA (1) | ZA201202199B (enExample) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT2464645T (lt) | 2009-07-27 | 2017-10-25 | Gilead Sciences, Inc. | Kondensuoti heterocikliniai junginiai, kaip jonų kanalų moduliatoriai |
| CA2772691C (en) * | 2009-09-28 | 2017-10-03 | F. Hoffmann-La Roche Ag | Benzoxazepin pi3k inhibitor compounds and methods of use |
| US8263633B2 (en) | 2009-09-28 | 2012-09-11 | F. Hoffman-La Roche Ag | Benzoxepin PI3K inhibitor compounds and methods of use |
| NZ604478A (en) | 2010-07-02 | 2014-12-24 | Gilead Sciences Inc | Fused heterocyclic compounds as ion channel modulators |
| CA2825966A1 (en) * | 2011-03-21 | 2012-09-27 | F. Hoffmann-La Roche Ag | Benzoxazepin compounds selective for pi3k p110 delta and methods of use |
| EP2707361B1 (en) | 2011-05-10 | 2017-08-23 | Gilead Sciences, Inc. | Fused heterocyclic compounds as sodium channel modulators |
| WO2012156379A1 (en) | 2011-05-13 | 2012-11-22 | Universität Zürich | PIK3/P110α INHIBITORS FOR PREVENTION OF RESTENOSIS BY APPLICATION AS AN IMPLANT COATING |
| TWI622583B (zh) | 2011-07-01 | 2018-05-01 | 基利科學股份有限公司 | 作為離子通道調節劑之稠合雜環化合物 |
| NO3175985T3 (enExample) * | 2011-07-01 | 2018-04-28 | ||
| JP2015507001A (ja) * | 2012-02-17 | 2015-03-05 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 三環式化合物及びその使用方法 |
| NZ702244A (en) * | 2012-06-08 | 2017-06-30 | Hoffmann La Roche | Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer |
| SG10201805807PA (en) | 2012-06-26 | 2018-08-30 | Del Mar Pharmaceuticals | Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof |
| CN102775395A (zh) * | 2012-07-12 | 2012-11-14 | 江苏七洲绿色化工股份有限公司 | 一种丙环唑的制备方法及丙环唑中间体 |
| AU2013299922B2 (en) * | 2012-08-07 | 2018-06-21 | Janssen Pharmaceutica Nv | Process for the preparation of heterocyclic ester derivatives |
| CA2897618A1 (en) * | 2013-03-13 | 2014-09-18 | F. Hoffmann-La Roche Ag | Process for making benzoxazepin compounds |
| CN105492011A (zh) | 2013-04-08 | 2016-04-13 | 丹尼斯·M·布朗 | 不理想给药化学化合物的治疗增效 |
| AU2014365079B2 (en) * | 2013-12-16 | 2017-07-06 | F. Hoffmann-La Roche Ag | Polymorphs of 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide, methods of production, and pharmaceutical uses thereof |
| AU2015228859A1 (en) | 2014-03-13 | 2016-07-07 | F. Hoffmann-La Roche Ag | Therapeutic combinations with estrogen receptor modulators |
| WO2016126726A1 (en) | 2015-02-02 | 2016-08-11 | Forma Therapeutics, Inc. | Bicyclic [4,6,0] hydroxamic acids as hdac6 inhibitors |
| US10214501B2 (en) | 2015-02-02 | 2019-02-26 | Forma Therapeutics, Inc. | 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors |
| AR104068A1 (es) | 2015-03-26 | 2017-06-21 | Hoffmann La Roche | Combinaciones de un compuesto inhibidor de fosfoinosítido 3-cinasa y un compuesto inhibidor de cdk4/6 para el tratamiento del cáncer |
| ES2770128T3 (es) * | 2015-04-30 | 2020-06-30 | Recordati Ag | Derivados de pirazol tricíclicos condensados útiles para modular los receptores farnesoide x |
| WO2016205334A1 (en) | 2015-06-16 | 2016-12-22 | Vascular Strategies Llc | Drug delivery and imaging chemical conjugate, formulations and methods of use thereof |
| US20160375033A1 (en) | 2015-06-29 | 2016-12-29 | Genentech, Inc. | Methods of treatment with taselisib |
| CN111848643A (zh) * | 2015-07-02 | 2020-10-30 | 豪夫迈·罗氏有限公司 | 苯并氧氮杂*噁唑烷酮化合物及其使用方法 |
| MY195002A (en) | 2015-07-02 | 2022-12-30 | Hoffmann La Roche | Benzoxazepin oxazolidinone compounds and methods of use |
| JP6873977B2 (ja) * | 2015-09-08 | 2021-05-19 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 三環式ｐｉ３ｋ阻害化合物及び使用方法 |
| US9721369B2 (en) * | 2015-09-15 | 2017-08-01 | Facebook, Inc. | Systems and methods for utilizing multiple map portions from multiple map data sources |
| US10555935B2 (en) | 2016-06-17 | 2020-02-11 | Forma Therapeutics, Inc. | 2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors |
| TW201815787A (zh) | 2016-09-23 | 2018-05-01 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| TW201813963A (zh) | 2016-09-23 | 2018-04-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| TW201825465A (zh) | 2016-09-23 | 2018-07-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| MX2019003714A (es) | 2016-09-29 | 2019-06-24 | Bayer Cropscience Ag | Novedosos derivados de imidazolilmetilo 5-sustituidos. |
| CA3044500A1 (en) * | 2016-12-15 | 2018-06-21 | F. Hoffmann-La Roche Ag | Process for the preparation of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino) propanamide |
| CN114984206A (zh) | 2017-03-02 | 2022-09-02 | 基因泰克公司 | Her2阳性乳腺癌的辅助治疗 |
| EP3615541B1 (en) | 2017-04-28 | 2025-03-19 | F. Hoffmann-La Roche AG | Polymorphs and solid forms of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and methods of production |
| ES2947411T3 (es) * | 2017-10-26 | 2023-08-08 | Xynomic Pharmaceuticals Inc | Sales cristalinas de un campo inhibidor de quinasa B-RAF |
| CN110785423B (zh) * | 2018-05-30 | 2022-07-26 | 江苏豪森药业集团有限公司 | 含三并环类衍生物抑制剂、其制备方法和应用 |
| CN111909157B (zh) * | 2019-05-07 | 2023-02-03 | 南京药石科技股份有限公司 | Ezh2抑制剂及其用途 |
| CN114599656A (zh) * | 2019-11-04 | 2022-06-07 | 贝达药业股份有限公司 | 咪唑烷酮类化合物及其制备方法与应用 |
| KR20220097466A (ko) * | 2019-11-04 | 2022-07-07 | 베타 파머수티컬 컴퍼니 리미티드 | 이미다졸리디논류 화합물 및 이들의 제조방법과 용도 |
| CA3159094A1 (en) * | 2019-11-25 | 2021-06-03 | Shanghai Hansoh Biomedical Co., Ltd. | Three fused ring derivative-containing salt or crystal form and pharmaceutical composition thereof |
| JP7652935B2 (ja) * | 2021-05-03 | 2025-03-27 | 山東軒竹医薬科技有限公司 | 三環式ユビキチン特異的プロテアーゼ１阻害剤及びその使用 |
| JP2024520920A (ja) * | 2021-05-13 | 2024-05-27 | 貝達薬業股▲ふん▼有限公司 | イミダゾリジノン類化合物の多形体、調製方法及びその使用 |
| IL308457A (en) | 2021-05-28 | 2024-01-01 | Genentech Inc | A process for preparing benzoxazepine oxazolidinone compounds |
| CN120202205A (zh) * | 2022-11-17 | 2025-06-24 | 微境生物医药科技(上海)有限公司 | 三并环类PI3Kα抑制剂及其制备方法和医药用途 |
| CN116003280B (zh) * | 2022-12-30 | 2024-11-19 | 合肥工业大学 | 一种芳基甲酰胺类化合物的光化学合成方法 |
| WO2025082533A1 (zh) * | 2023-10-21 | 2025-04-24 | 上海轶诺药业有限公司 | 一种稠环化合物及其制备和应用 |
| WO2025237374A1 (zh) * | 2024-05-16 | 2025-11-20 | 微境生物医药科技(上海)有限公司 | PI3Kα抑制剂及其制备方法和医药用途 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| GB8504702D0 (en) | 1985-02-23 | 1985-03-27 | Zyma Sa | Tricyclic compounds |
| US5583024A (en) | 1985-12-02 | 1996-12-10 | The Regents Of The University Of California | Recombinant expression of Coleoptera luciferase |
| FR2677356B1 (fr) | 1991-06-05 | 1995-03-17 | Sanofi Sa | Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant. |
| KR0126300B1 (ko) | 1992-12-28 | 1997-12-26 | 나이토 하루오 | 레티노이드 수용체(rar)에 결합하는 헤테로고리 탄산유도체 |
| AU678503B2 (en) * | 1993-09-24 | 1997-05-29 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds and their use as squalene synthetase inhibitors |
| US5543523A (en) | 1994-11-15 | 1996-08-06 | Regents Of The University Of Minnesota | Method and intermediates for the synthesis of korupensamines |
| JPH08336393A (ja) | 1995-04-13 | 1996-12-24 | Mitsubishi Chem Corp | 光学活性なγ−置換−β−ヒドロキシ酪酸エステルの製造法 |
| WO1997019087A1 (en) | 1995-11-17 | 1997-05-29 | E.I. Du Pont De Nemours And Company | Tricyclic herbicidal heterocycles |
| US6602677B1 (en) | 1997-09-19 | 2003-08-05 | Promega Corporation | Thermostable luciferases and methods of production |
| DE19908533A1 (de) | 1999-02-26 | 2000-08-31 | Aventis Pharma Gmbh | Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen |
| DE19908537A1 (de) | 1999-02-26 | 2000-08-31 | Aventis Pharma Gmbh | Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
| DE19908538A1 (de) | 1999-02-26 | 2000-08-31 | Aventis Pharma Gmbh | Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen |
| DE19908535A1 (de) | 1999-02-26 | 2000-08-31 | Aventis Pharma Gmbh | Verwendung von polycyclischen Thiazol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
| US7273880B2 (en) | 1999-06-30 | 2007-09-25 | H. Lunbeck A/S | Selective NPY (Y5) antagonists |
| WO2001064675A1 (en) | 2000-03-03 | 2001-09-07 | Novartis Ag | Condensed thiazolamines and their use as neuropeptide y5 antagonists |
| EP1355875A1 (en) | 2001-02-02 | 2003-10-29 | Schering Corporation | 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists |
| TWI232863B (en) * | 2001-06-11 | 2005-05-21 | Akzo Nobel Nv | Benzoxazepine derivatives |
| CA2492922A1 (en) | 2002-07-19 | 2004-01-29 | Pharmacia Corporation | Substituted thiophene carboxamide compounds for the treatment of inflammation |
| EP1594495A1 (en) * | 2003-02-07 | 2005-11-16 | Warner-Lambert Company LLC | Oxazolidinone derivates n-substituted by a tricyclic ring, for use as antibacterial agents |
| TW200510356A (en) * | 2003-08-01 | 2005-03-16 | Takeda Chemical Industries Ltd | Benzoxaepine compounds |
| US20050239767A1 (en) | 2003-10-28 | 2005-10-27 | Chan Michael K | Intermolecular SNAr of the heterocycle-activated nitro and fluoro groups-application in the synthesis of polyazamacrocyclic ligands |
| CA2571807A1 (en) * | 2004-07-01 | 2006-01-19 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
| KR20070064660A (ko) | 2004-10-07 | 2007-06-21 | 베링거 인겔하임 인터내셔날 게엠베하 | Ｐｉ３ 키나제 |
| CN103524392B (zh) | 2005-10-07 | 2018-06-01 | 埃克塞利希斯股份有限公司 | 作为用于治疗增生性疾病的mek 抑制剂的吖丁啶 |
| US20070238746A1 (en) * | 2006-04-06 | 2007-10-11 | Trixi Brandl | Thiazolyl-dihydro-chinazoline |
| US20070238718A1 (en) * | 2006-04-06 | 2007-10-11 | Matthias Grauert | Thiazolyl-dihydro-indazole |
| GB0610866D0 (en) * | 2006-06-02 | 2006-07-12 | Hammersmith Imanet Ltd | Novel in vivo imaging compounds |
| WO2008014483A1 (en) * | 2006-07-28 | 2008-01-31 | Alcan Packaging Flexible France | Coextruded film with polylactic acid (pla) and ethylene vinyl acetate (eva) |
| US8877791B2 (en) | 2006-08-04 | 2014-11-04 | Beth Israel Deaconess Medical Center, Inc. | Inhibitors of pyruvate kinase and methods of treating disease |
| US8779154B2 (en) | 2006-09-26 | 2014-07-15 | Qinglin Che | Fused ring compounds for inflammation and immune-related uses |
| KR101578674B1 (ko) * | 2006-12-29 | 2015-12-18 | 아비에 도이치란트 게엠베하 운트 콤파니 카게 | 카복스아미드 화합물 및 칼페인 억제제로서의 이의 용도 |
| AU2008302703B2 (en) | 2007-09-19 | 2013-11-07 | The Regents Of The University Of California | Positron emission tomography probes for imaging immune activation and selected cancers |
| CA2719032C (en) * | 2008-03-31 | 2016-11-08 | Steven Do | Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use |
| WO2010043676A1 (en) * | 2008-10-17 | 2010-04-22 | Boehringer Ingelheim International Gmbh | Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (pi3-kinases) inhibitor |
| US8263633B2 (en) * | 2009-09-28 | 2012-09-11 | F. Hoffman-La Roche Ag | Benzoxepin PI3K inhibitor compounds and methods of use |
| CA2772691C (en) * | 2009-09-28 | 2017-10-03 | F. Hoffmann-La Roche Ag | Benzoxazepin pi3k inhibitor compounds and methods of use |
-
2010
- 2010-09-27 CA CA2772691A patent/CA2772691C/en active Active
- 2010-09-27 KR KR1020127010974A patent/KR101428346B1/ko active Active
- 2010-09-27 EP EP10757213.3A patent/EP2483278B1/en active Active
- 2010-09-27 ES ES10757213.3T patent/ES2444779T3/es active Active
- 2010-09-27 DK DK10757213.3T patent/DK2483278T3/da active
- 2010-09-27 SI SI201030536T patent/SI2483278T1/sl unknown
- 2010-09-27 AU AU2010299816A patent/AU2010299816C1/en active Active
- 2010-09-27 MY MYPI2015002473A patent/MY184074A/en unknown
- 2010-09-27 JP JP2012530282A patent/JP5540101B2/ja active Active
- 2010-09-27 US US12/890,812 patent/US8242104B2/en active Active
- 2010-09-27 MY MYPI2012000823A patent/MY160064A/en unknown
- 2010-09-27 RU RU2016105810A patent/RU2654068C1/ru active
- 2010-09-27 WO PCT/EP2010/064208 patent/WO2011036280A1/en not_active Ceased
- 2010-09-27 NZ NZ597833A patent/NZ597833A/en unknown
- 2010-09-27 BR BR112012006807-5A patent/BR112012006807A2/pt not_active Application Discontinuation
- 2010-09-27 EP EP13193562.9A patent/EP2711368B1/en active Active
- 2010-09-27 TW TW099132661A patent/TWI423980B/zh active
- 2010-09-27 CN CN201510043641.XA patent/CN104744491B/zh active Active
- 2010-09-27 EP EP20140190276 patent/EP2845592A1/en not_active Withdrawn
- 2010-09-27 MX MX2012003591A patent/MX2012003591A/es active IP Right Grant
- 2010-09-27 RU RU2012117398/04A patent/RU2600927C2/ru active
- 2010-09-27 PL PL10757213T patent/PL2483278T3/pl unknown
- 2010-09-27 AR ARP100103491A patent/AR078187A1/es unknown
- 2010-09-27 PE PE2012000390A patent/PE20121025A1/es active IP Right Grant
- 2010-09-27 SG SG10201405049RA patent/SG10201405049RA/en unknown
- 2010-09-27 ES ES13193562T patent/ES2570569T3/es active Active
- 2010-09-27 CN CN201080053938.XA patent/CN102762576B/zh active Active
- 2010-09-27 PT PT107572133T patent/PT2483278E/pt unknown
- 2010-09-27 RS RS20140060A patent/RS53164B/sr unknown
- 2010-09-27 HR HRP20140229AT patent/HRP20140229T1/hr unknown
-
2012
- 2012-01-10 CO CO12002995A patent/CO6491026A2/es active IP Right Grant
- 2012-01-16 IL IL217558A patent/IL217558A/en active IP Right Grant
- 2012-02-15 MA MA34637A patent/MA33531B1/fr unknown
- 2012-03-13 CR CR20120121A patent/CR20120121A/es unknown
- 2012-03-26 ZA ZA2012/02199A patent/ZA201202199B/en unknown
- 2012-03-27 CL CL2012000754A patent/CL2012000754A1/es unknown
- 2012-03-28 EC ECSP12011755 patent/ECSP12011755A/es unknown
- 2012-05-22 US US13/477,587 patent/US8343955B2/en active Active
- 2012-11-20 US US13/681,763 patent/US8586574B2/en active Active
-
2013
- 2013-10-07 US US14/047,206 patent/US8785626B2/en active Active
- 2013-11-01 JP JP2013228826A patent/JP5625101B2/ja active Active
-
2014
- 2014-06-05 US US14/297,142 patent/US9198918B2/en active Active
-
2015
- 2015-05-28 IL IL239081A patent/IL239081B/en active IP Right Grant
- 2015-11-03 US US14/930,929 patent/US9546178B2/en active Active
-
2016
- 2016-12-05 US US15/368,937 patent/US9670228B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014070075A5 (enExample) | ||
| NZ597833A (en) | Benzoxazepin pi3k inhibitor compounds and methods of use | |
| RU2017114355A (ru) | Производные нафтиридина в качестве антагонистов альфа v бета 6 интегрина для лечения, в частности, фиброзных заболеваний | |
| HRP20210981T1 (hr) | Imidazolonil kinolini i njihova uporaba kao inhibitori atm kinaze | |
| JP2013529611A5 (enExample) | ||
| HRP20161674T1 (hr) | 4-(8-METOKSI-1-((1-METOKSIPROPAN-2-IL)-2-(TETRAHIDRO-2H-PIRAN-4-IL)-1H-IMIDAZO[4,5-c]KINOLIN-7-IL)-3,5-DIMETILIZOKSAZOL I NJEGOVA UPOTREBA KAO INHIBITORA BROMODOMENE | |
| HRP20171696T1 (hr) | 3,4-dihidroizokinolin-2(1h)-ilni spojevi | |
| JP2016501221A5 (enExample) | ||
| JP2013508382A5 (enExample) | ||
| MX2010001745A (es) | Imidazoles fusionados para el tratamiento del cancer. | |
| AR102487A1 (es) | Derivados de feniltriazol sustituido con hidroxialquilo y sus usos | |
| HRP20150489T1 (hr) | Imidazo[4,5-c]kinolini kao inhibitori dna-pk | |
| JO3392B1 (ar) | مركبات عطرية حلقية غير متجانسة كمركبات مضادة للالتهاب | |
| WO2016160617A3 (en) | Inhibitors of cyclin-dependent kinases | |
| JP2011517457A5 (enExample) | ||
| MX383051B (es) | Compuestos que inhiben eif4a y métodos relacionados a los mismos. | |
| JP2013510124A5 (enExample) | ||
| JP2017524668A5 (enExample) | ||
| NZ601077A (en) | Use of an adrenal hormone-modifying agent | |
| IL274936B2 (en) | Transmuted heterocyclic bicyclic compounds as prmt5 inhibitors | |
| NZ586579A (en) | Fused heterocyclic derivatives and methods of use as c-met inhibitors | |
| JP2014533745A5 (enExample) | ||
| RU2021102805A (ru) | 4,6-ЗАМЕЩЕННЫЕ ПИРАЗОЛО[1,5-a]ПИРАЗИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ЯНУС-КИНАЗЫ | |
| JP2013502441A5 (enExample) | ||
| EP4446301A3 (en) | Heterocyclic compounds for cancer imaging and treatment and methods for their use |